Abstract: Techniques and systems for controlling a network video camera with physical privacy feedback are provided. For example, computing device, a method, and a computer-program product may be provided. The computing device may include one or more lenses and one or more blocking mechanisms, wherein the one or more blocking mechanisms are configured to selectively block the one or more lenses from capturing video images, and wherein the one or more blocking mechanisms include a physical body that provides visible feedback that the one or more lenses are blocked. The computing device, method, and computer-program product may include detecting an occurrence of an event, and activating the one or more blocking mechanisms to block the one or more lenses from capturing video images, wherein the one or more blocking mechanisms are activated to block the one or more lenses when the occurrence of the event is detected.

Abstract: Techniques and systems are provided for controlling a network video camera with physical privacy feedback to capture one or more images of a scene. For example, computing device, a method, and a computer-program product may be provided. The computing device may include one or more lenses and one or more blocking mechanisms, wherein the one or more blocking mechanisms are configured to selectively block the one or more lenses from capturing video images, and wherein the one or more blocking mechanisms include a physical body that provides visible feedback that the one or more lenses are blocked. The computing device, method, and computer-program product may include detecting movement of a blocking mechanism from a first position in which a lens is exposed to a second position in which the lens is blocked, and capturing one or more images of a scene, wherein the one or more images of the scene are captured when the movement of the blocking mechanism is detected.

Abstract: The present invention describes a method of reducing solid tumors in a subject having an adenoid cystic carcinoma comprising administering a therapeutically effective amount of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-yl]-1H-quinolin-2-one or a pharmaceutically acceptable salt thereof.

Abstract: Disclosed is a microscope system for imaging an object within an eye, wherein the object is a phase object. The microscope system includes imaging optics for generating images of an object plane of the imaging optics in an image plane of the imaging optics by using imaging light. The object plane is optically conjugate to the image plane. The microscope system is configured to store focus shift data representing a focus shift. The focus shift is generated by a different effect on the imaging light generated by phase objects as compared to amplitude objects. The microscope system is configured to image the object depending on the focus shift data.

Abstract: Sulfonylethyl and thioethyl phosphorodiamidates, their preparation and intermediates in their preparation, formulations containing them, and their pharmaceutical use. The compounds are useful for treating cancer, alone and in combination with other anticancer therapies.

Abstract: Compounds of the following formula are provided: In the Formula (I), R1 is —X—R1?; in which R1? is optionally substituted lower alkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted heterocyclyl, and X is —NH—. R2 is lower alkyl optionally substituted with one, two or three groups chosen from hydroxy, lower alkoxy, and halogen. And R3 is —NR4R5; in which R4 is hydrogen and R5 is lower alkyl substituted with amino; or (ii) R4 and R5 are both lower alkyl optionally substituted with one, two or three groups chosen from hydroxy and amino. It is to be understood that R1? is not cyclohexylmethyl, phenyl, substituted phenyl, benzyl, phenylethyl, or m-hydroxybenzyl. The compounds inhibit CDK-2 activity and are useful for treating disorders characterized by undesirable cell proliferation.

Abstract: Method and apparatus for a frequency diverse array. Radio frequency signals are generated and applied to a power divider network. A progressive frequency shift is applied to all radio frequency signals across all spatial channels. Amplitude weighting signals are applied for sidelobe control. Phase control is included for channel compensation and to provide nominal beam steering. The progressive frequency offsets generate a new term which cause the antenna beam to focus in different directions as a function of range. Alternative embodiments generate different waveforms to be applied to each radiating element, permitting the transmission of multiple signals at the same time.

Abstract: Sulfonylethyl and thioethyl phosphorodiamidates, their preparation and intermediates in their preparation, formulations containing them, and their pharmaceutical use. The compounds are useful for treating cancer, alone and in combination with other anticancer therapies.

Abstract: A method of sensitizing a mammal, especially a human, to another anticancer therapy by administering a sensitizing effective amount of a GST-activated anticancer compound. A method of ameliorating a side effect of another anticancer therapy in a mammal, especially a human, by administering an ameliorating effective amount of a GST-activated anticancer compound. Pharmaceutical compositions for the methods. The GST-activated anticancer compound is preferably a compound of U.S. Pat. No. 5,556,942, and more preferably canfosfamide, especially as the hydrochloride salt.

Abstract: Compounds of the following formula are provided: In the Formula (I), R1 is —X—R1?; in which R1? is optionally substituted lower alkyl, optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted heterocyclyl, and X is —NH—. R2 is lower alkyl optionally substituted with one, two or three groups chosen from hydroxy, lower alkoxy, and halogen. And R3 is —NR4R5; in which R4 is hydrogen and R5 is lower alkyl substituted with amino; or (ii) R4 and R5 are both lower alkyl optionally substituted with one, two or three groups chosen from hydroxy and amino. It is to be understood that R1? is not cyclohexylmethyl, phenyl, substituted phenyl, benzyl, phenylethyl, or m-hydroxybenzyl. The compounds inhibit CDK-2 activity and are useful for treating disorders characterized by undesirable cell proliferation.

Abstract: A headset adapted for use with a cellular telephone comprises an earphone shaped to fit in the ear of a user, an earphone arm extending from the earphone to an earphone arm pivot end, a support protrusion extending from the earphone arm pivot end to rest under the ear of the user when wearing the headset, a telescoping arm extending from a microphone to a microphone arm pivot end, the microphone arm pivot end pivotally connected to the earphone arm, the telescoping arm having an arcuate shape.